Moderna’s COVID-19 Vaccine To Move Faster Into Phase III
Three Veterans Recruited To Add Experience To Team
mRNA company confident as it heads towards Phase II trials, but says efficacy and approval will not be a ‘binary event’.
mRNA company confident as it heads towards Phase II trials, but says efficacy and approval will not be a ‘binary event’.